Stage III Pancreatic Cancer AJCC v8 trials recruiting in Wisconsin

All Stage III Pancreatic Cancer AJCC v8 trials nationally

Cities in Wisconsin

Recruiting trials in Wisconsin

• A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
  NCT06906562 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Wisconsin: Chippewa Falls, Green Bay, Madison, Milwaukee
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Wisconsin: Ashland, Green Bay, Hayward, La Crosse
• Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
  NCT06958328 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Wisconsin: Antigo, Burlington, Eau Claire, Germantown
• Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  NCT04172532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Wisconsin: Madison
• Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
  NCT05372614 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Wisconsin: Madison